Ol015758h Si 001
Ol015758h Si 001
Ol015758h Si 001
SUPPORTING INFORMATION
TABLE OF CONTENTS
C. NMR spectra for compounds 2, 3, 11, 12, 2’ and 3’ and lactone 1’; X-ray structure of
lactone 19.
S1
A. Experimental procedures and characterization data for compounds 1-3, 10-12,
techniques. The anhydrous solvents were purchased from Aldrich and used as received. i-
Pr2NH and Et3N were freshly distilled from CaH2 under N2 atmosphere. n-Butyllithium
(1.6 M solution in hexane) was purchased from Aldrich and titrated prior to use
trimethoxypropane were purchased from Aldrich and distilled prior to use. Flash
chromatography was performed on Merck silica gel 60 (0.040-0.063 mm) using nitrogen
pressure. Analytical thin-layer chromatography (TLC) was carried out on precoated (0.25
mm) Merck silica gel F-254 plates. Melting points were determined on an electrothermal
The preparation and characterization data of 4-9 have been reported previously.1
0 °C were successively added TBAF (5 equiv) and acetic acid (2 equiv). After being
allowed to warm to room temperature, the reaction mixture was stirred until all of the
substrate was consumed (2 h). The reaction mixture was diluted with EtOAc, quenched
(1) Guindon, Y.; Yoakim, C.; Gorys, V.; Ogilvie, W.W.; Delorme, D.; Renaud, J.; Robinson, G.; Lavallée, J.-
F.; Slassi, A.; Jung, G.; Rancourt, J.; Durkin, K.; Liotta, D. J. Org. Chem. 1994, 59, 1166
(2) Guindon, Y.; Faucher, A.-M.; Bourque, É.; Caron, V.; Jung, G.; Landry, S. R. J. Org. Chem. 1997, 62,
9276.
S2
with a phosphate buffer (pH 7.2) solution, and then extracted twice with EtOAc. The
combined organic extracts were washed with a saturated aqueous solution of NaHCO3 and
brine, dried with MgSO4, filtered, and concentrated under reduced pressure. The crude oil
was purified by flash column chromatography to afford 1 as a white solid (81%): mp 70-71
°C, Rf 0.12 (hexanes-EtOAC, 6:4); IR (neat) υmax 3550, 3500, 1720 cm-1; MS (FAB) 360
(19, MH), 287 (49), 230 (28), 157 (19), 57 (100); 1H NMR (400 MHz, CDCl3) δ 1.35 (s,
3H), 1.46 (s, 9H), 1.68-1.77 (m, 1H), 2.09-2.13 (m, 1H), 2.50 (dd, J = 7.2, 3.6 Hz, 1H),
3.37 (d, J = 5.2 Hz, 1H), 3.81-3.88 (m, 2H), 4.03-4.08 (m, 1H), 7.32 (t, J = 7.2 Hz, 2H),
7.40 (t, J = 7.2 Hz, 1H), 7.60 (d, J = 6.8 Hz, 2H); 13C NMR (50 MHz, CDCl3) δ 18.8, 28.0,
33.3, 54.5, 61.9, 75.6, 82.4, 126.5, 128.8, 129.4, 138.1, 173.1; HRMS (FAB) calcd for
C16H25O480Se: 361.0918, found: 361.0933 (-4.2 ppm). Anal. calcd for C16H24O4Se: C
Compound 10: To a cold (0 °C) stirred solution of iPr2NH (1.3 equiv) in THF under
resultant mixture was stirred for 30 min and then cooled to -78 °C before tert-butyl 2-
phenylselenopropionate2 (9.4 g, 33 mmol) in THF was added. After the reaction mixture
g, 30 mmol) was added, and the resultant solution was stirred at -78 °C until all of the
substrate was consumed (4 h). The cold bath was removed, and the reaction mixture was
quenched with a saturated aq NH4Cl. The mixture was then extracted successively with
Et2O (1X) and CH2Cl2 (2X), dried with anhydrous MgSO4, filtered, and concentrated under
(3) Chaubet, F.; Nguyen Van Duong, M.; Courtieu, J.; Gaudemer, A. Can. J. Chem. 1991, 69, 1107.
S3
reduced pressure. Purification of the crude material by flash column chromatography
(CH2Cl2:EtOAc, 10:1) afforded two diastereomers (12.0 g, 82%). To a solution of the less
polar syn isomer (Rf 0.33; CH2Cl2-EtOAc, 10:1) in CH2Cl2 was added a solution of 4M
HCl in dioxane (4 equiv) at room temperature. The mixture was stirred until the starting
material was no longer evident by TLC (1h). After concentration of the solvent, the residue
was dissolved in water and extracted twice with ether. The cold (0 °C) aqueous solution
was treated with a 1M aq solution of NaOH until a neutral pH was achieved and the
resultant solution was extracted thrice with CH2Cl2. The combined CH2Cl2 extracts were
washed with brine and dried with Na2SO4. Removal of the solvent gave the desired amino
ester 10 (syn) as a yellow oil: Rf 0.19 (CH2Cl2-MeOH, 30:1; Al2O3); IR (neat) υmax 1705
cm-1; MS (FAB) 388 (100, MH), 386 (52), 332 (21), 230 (7), 174 (16); 1H NMR (400
MHz, CDCl3) δ 1.10 (t, J = 7.3 Hz, 3H), 1.35 (s, 9H), 1.43 (s, 3H), 1.45-1.52 (m, 1H), 1.57-
1.68 (m, 1H), 2.62 (dq, J = 11.4, 7.0 Hz, 1H), 2.71 (dq, J = 11.4, 7.0 Hz, 1H), 2.76 (ddd, J
= 12.4, 10.8, 3.6 Hz, 1H), 2.97 (td, J = 12.1, 4.1 Hz, 1H), 4.15 (dd, J = 10.2, 1.9 Hz, 1H),
7.26-7.37 (m, 5H); 13C NMR (100 MHz, CDCl3) δ 15.1, 17.3, 27.8, 28.2, 30.2, 43.7, 48.6,
56.3, 75.0, 81.0, 127.3, 128.5, 128.9, 138.1, 138.2, 171.9; HRMS (FAB) calcd for
C18H30O3N80Se: 388.1391, found: 388.1375 (+4.1 ppm). Anal. calcd for C18H29O3NSe: C
solution of 1 in CH2Cl2 (0.1 M) at room temperature was added either Et3B (1.3 equiv)/air,
DIEA (1.8 equiv)/Bu2BOTf (1.3 equiv), or DIEA (2.2 equiv)/Me2SiCl2 (1.8 equiv). The
S4
resultant mixture was stirred for 1-2 h, cooled to 0 oC, and subjected to reduction as
described below.
cooled (0 oC) stirred solution of 1 in CH2Cl2 (0.1 M) were added Bu3SnH (2 equiv) and
either Et3B (0.2 equiv) or AIBN (0.2 equiv; initiation by sunlamp irradiation). The
resultant solution was stirred for 1-2 h, after which 0.2 equiv of Et3B was added every 30
min until all of the substrate was consumed. 1,3-Dinitrobenzene (0.2 equiv) was then
added, and the resultant mixture was stirred at 0 oC for 15 min before being allowed to
warm to room temperature. After concentration under reduced pressure, the crude residue
was analyzed by 1H NMR to determine the anti:syn ratio. The crude mixture of anti and
syn products was derivatized as boronates, for which ratios were determined by 1H NMR
and GC. The boronate mixture was then treated with silica gel and MeOH (25 mL) to
regenerate the diol products, which were separated by flash column chromatography.
Compound 2: colorless oil; Rf 0.12 (hexanes-EtOAc, 1:1); IR (neat) υmax 3400, 1715
cm-1; MS (FAB) 205 (10, MH), 149 (76), 131 (52), 89(9); 1H NMR (400 MHz, CDCl3) δ:
1.18 (d, J = 6.8 Hz, 3H), 1.47 (s, 9H), 1.69-1.76 (m, 2H), 2.44 (quint, J = 7.2 Hz, 1H), 2.63
(dd, J = 6.0, 4.8 Hz, 1H), 3.42 (d, J = 5.6 Hz, 1H), 3.84-3.91 (m, 3H); 13C NMR (100 MHz,
CDCl3) δ: 14.2, 28.1, 36.0, 46.1, 61.5, 73.7, 81.4, 175.4 ; HRMS (FAB) calcd for
υmax 3400, 1715 cm-1; MS (FAB) m/z 205 (21, MH+), 149 (100), 131 (66), 113 (19), 77
(16); 1H NMR (400 MHz, CDCl3) δ: 1.17 (d, J = 7.2 Hz, 3H), 1.46 (s, 9H), 1.53-1.60 (m,
S5
1H), 1.72-1.81 (m, 1H), 2.43 (qd, J = 7.2, 4.0 Hz, 1H), 2.55 (t, J = 5.2 Hz, 1H), 3.29 (d, J =
3.6 Hz, 1H), 3.85 (q, J = 4.8 Hz, 2H), 4.07-4.12 (m, 1H); 13C NMR (100 MHz, CDCl3) δ:
11.4, 28.0, 35.3, 45.4, 61.5, 71.8, 81.2, 175.4; HRMS (FAB) calcd for C10H21O4: 205.1440,
Compounds 11 (anti) and 12 (syn) were obtained from the radical reduction of
phenylselenoester 10. After the anti:syn ratio of the crude reduced products was
determined by 1H NMR, the mixture was treated with di-tert-butyl dicarbonate (2.1 equiv)
in THF (0.02M) for 12 h at room temperature. After concentration, the residue was
oil: Rf 0.21 (hexanes-EtOAc, 8:2); MS (FAB) 332 (51, MH), 298 (8), 232 (62), 176 (100);
1
H NMR (400 MHz, CDCl3, 3:1 mixture of diastereomers) δ 1.10 (t, J = 7.2 Hz, 3H), 1.17
(d, J = 7.2 Hz, 3H), 1.44 (s, 9H), 1.45 (s, 9H), 1.58-1.68 (m, 2H), 2.33-2.42 (m, 1H), 2.98-
13
3.17 (m, 2H), 3.21-3.30 (m, 1H), 3.63-3.73 (m, 1H), 4.08-4.14 (m, 1H); C NMR (100
MHz, CDCl3, 3:1 mixture of diastereomers) δ 12.7, 13.7, 28.1, 28.5, 29.1, 33.2, 42.2, 43.3,
46.0, 69.0, 79.7, 80.5, 156.4, 175.1; HRMS (FAB) calcd for C17H34O5N: 332.2437, found:
υmax 1725 cm-1; MS (FAB) 398 (45, MH), 343 (90), 297 (37), 241 (91), 133 (100); 1H
NMR (400 MHz, CDCl3) δ 0.62 (q, J = 7.6 Hz, 2H), 0.81 (t, J = 7.6 Hz, 3H), 1.36 (s, 3H),
1.39 (s, 9H), 1.82 (qd, J = 12.4, 5.2 Hz, 1H), 2.34 (dd, J = 13.6, 2.0 Hz, 1H), 3.97 (td, J =
12.4, 2.8 Hz, 1H), 4.06-4.10 (m, 1H), 4.43 (dd, J = 11.6, 2.8 Hz, 1H), 7.30 (t, J = 7.2, 2H),
7.39 (t, J = 7.6 Hz, 1H), 7.60 (d, J = 8.0 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 7.6, 16.6,
S6
27.6, 27.8, 53.0, 61.8, 74.4, 81.2, 126.5, 128.8, 129.3, 138.0, 171.6; 11B NMR (400 MHz,
CDCl3) δ 31 ppm; HRMS (EI) calcd for C18H27O411B80Se: 398.1168, found: 398.1157 (2.7
ppm). Anal. calcd for C18H27O4BSe: C 54.48, H 6.85; found: C 54.58, H 7.20.
υmax 1730 cm-1; MS (FAB) 426 (MH, 11), 371 (22), 241 (29), 167 (19), 57 (100); 1H NMR
(400 MHz, CDCl3) δ 0.63 (t, J = 6.4 Hz, 2H), 0.82 (t, J = 7.2 Hz, 3H), 0.88-1.34 (m, 1H),
1.35 (s, 3H), 1.38 (s, 9H), 1.76-1.87 (m, 1H), 2.34 (dd, J = 14.0, 1.6 Hz, 1H), 3.96 (td, J =
12.4, 2.8 Hz, 1H), 4.06-4.10 (m, 1H), 4.43 (dd, J = 11.6, 2.4 Hz, 1H), 7.30 (t, J = 6.8, 2H),
7.39 (t, J = 7.2 Hz, 1H), 7.56 (d, J = 8.0 Hz, 2H); 13
C NMR (100 MHz, CDCl3) δ 13.9,
11
16.7, 25.3, 26.2, 27.7, 27.8, 53.1, 61.8, 74.4, 81.2, 126.5, 128.8, 129.3, 138.0, 171.6; B
NMR (400 MHz, CDCl3) δ 31 ppm; HRMS (FAB) calcd for C20H31O411B80Se: 426.1481,
found: 426.1462 (+4.4 ppm). Anal. calcd for C20H31O4BSe: C 56.49, H 7.35; found: C
56.77, H 7.65.
Ethylboronate 2’ (anti) was prepared from reduced product 2 (anti) and isolated as a
colorless oil. Capillary GC analyses were performed on a Hewlett Packard 6890 instrument
using a 0.25 mm × 30 m SE-30 column. GC tR 7.77 min (tinj. 280 °C, tFID 280 °C, split
method, 83:1, 0.5 mL/min, program 150 °C/8min, 20 °C/min, 280/ 5min). Rf 0.58
(hexanes-EtOAc, 40:60); IR (neat) υmax 1735 cm-1; 1H NMR (400 MHz, CDCl3) δ 0.65 (q,
J = 7.8 Hz, 2H), 0.85 (t, J = 7.8 Hz, 3H), 1.08 (d, J = 7.1 Hz, 3H), 1.46 (s, 9H), 1.63-1.75
(m, 1H), 1.90 (qd, J = 11.0, 2.9 Hz, 1H), 2.45 (quint, J = 7.1 Hz, 1H), 3.92 (td, J = 11.1, 3.1
Hz, 1H), 3.99-4.04 (m, 1H), 4.07-4.12 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 7.7, 12.5,
S7
Ethylboronate 3’ (syn) was prepared from reduced product 3 (syn) and isolated as a
colorless oil. GC tR 7.40 min (tinj. 280 °C, tFID 280 °C, split method, 83:1, 0.5 mL/min,
program 150 °C/8min, 20 °C/min, 280/ 5min). Rf 0.58 (hexanes-EtOAc, 40:60); IR (neat)
υmax 1730 cm-1; 1H NMR (400 MHz, CDCl3) δ 0.66 (q, J = 7.9 Hz, 2H), 0.86 (t, J = 7.9 Hz,
3H), 1.22 (d, J = 7.0 Hz, 3H), 1.45 (s, 9H), 1.74-1.82 (m, 1H), 1.90 (qd, J = 10.8, 3.2 Hz,
1H), 2.40 (quint, J = 7.1 Hz, 1H), 3.93 (td, J = 11.0, 3.3 Hz, 1H), 3.99-4.07 (m, 2H); 13C
A rigorous stereochemical assignment was performed for compound 1 and its syn
counterpart 19 (not presented in the present work), which were then transformed into
lactones. For lactone 19’, X-ray structure was elucidated. The 1H NMR spectra of lactones
derivatized from reduced products 2 and 3 were identical to those reported previously.2
Compound 19, yellow oil (83%). Rf 0.12 (hexanes-EtOAc, 6:4); IR (neat) υmax
3450, 1710 cm-1; MS (FAB) 360 (19, MH), 287 (49), 230 (28), 157 (19), 57 (100); 1H
NMR (400 MHz, CDCl3) δ 1.32 (s, 3H), 1.38 (s, 9H), 1.61-1.64 (m, 1H), 1.86-1.92 (m,
1H), 2.66 (t, J = 5.2 Hz, 1H), 3.57 (s, 1H), 3.78-3.88 (m, 2H), 4.07 (d, J = 10.2 Hz, 1H),
7.32 (t, J = 8 Hz, 2H), 7.40 (t, J = 8 Hz, 1H), 7.63 (d, J = 8 Hz, 2H); 13C NMR (100 MHz,
CDCl3) δ 17.4, 27.8, 33.4, 57.1, 61.7, 73.3, 81.9, 126.4, 128.9, 129.4, 138.2, 172.4; HRMS
S8
(FAB) calcd for C16H25O480Se: 361.0918, found: 361.0929 (-3.1 ppm); Anal. Calcd for
Lactone 19’. To a solution of the syn phenylseleno ester 19 (120 mg, 0.33 mmol) in
CH2Cl2 (3.4 mL) at 0 °C was added Bu2BOTf (440 µL, 0.44 mmol). The reaction mixture
was stirred 1 min at the same temperature, and N,N-diisopropylethylamine (200 µL, 1.15
mmol) ) was added. After an additional 2 min, the solvent was removed, and the crude
residue was purified by flash chromatography to give the desired product 19’ as a white
solid (42 mg, 43%). Mp = 105-106 °C, Rf 0.28 (hexanes-EtOAc, 1:1); IR (CDCl3) υmax
3620, 1715 cm-1; MS (FAB) m/z 287 (100, MH+), 157 (62), 136 (63), 107 (31), 89 (36), 77
(47); 1H NMR (400 MHz, CDCl3) δ 1.52 (s,3H), 1.95 (qd, J = 14.6, 4.8 Hz, 1H), 2.33 (s,
1H), 2.47-2.56 (m, 1H), 4.22-4.30 (m, 1H), 4.35-4.40 (m, 1H), 4.63 (td, J = 10.8, 4.4 Hz,
1H), 7.34 (t, J = 7.6 Hz, 2H), 7.43 (t, J = 7.6 Hz, 1H), 7.61 (d, J = 8.4 Hz, 2H); 13C NMR
(100 MHz, CDCl3) δ 21.0, 27.9, 49.9, 65.5, 71.5, 126.3, 129.2, 130.0, 138.0, 172.3; HRMS
(FAB) calcd for C12H14O380Se: 287.0186, found: 287.0179 (2.6 ppm); Anal. Calcd for
Lactone 1’, prepared from 1 (anti), was obtained as a yellow oil: Rf 0.19 (hexanes-
EtOAc, 1:1); MS (FAB) m/z 287 (44, MH+), 154 (100), 136 (88), 107 (32), 89 (35), 77
(40); 1H NMR (400 MHz, CDCl3) δ 1.59 (s,3H), 2.12-2.18 (m, 2H), 2.83 (d, J = 6.8, 1H),
3.79 (q, J = 6.4 Hz, 1H), 4.23-4.29 (m, 1H), 4.50-4.59 (m, 1H), 7.35 (t, J = 7.2 Hz, 2H),
7.44 (t, J = 6.8 Hz, 1H), 7.61 (d, J = 8.0 Hz, 2H); 13
C NMR (100 MHz, CDCl3) δ 23.3,
S9
The relative stereochemistry of the reduced products 11 and 12 was elucidated from
NMR studies of their corresponding benzylidene acetals 20 and 21. Acetal 20, which is
derivatized from anti product 11, is characterized by two large coupling constants (11Hz)
between Ha-Hc and Hc-Hd. The small coupling constants (2.5 Hz) between Ha-Hc and Hb-
Hc confirmed the syn relative stereochemistry between Me at C-2 and the hydroxyl group
Benzylidene acetal (20 and 21). To an inseparable (3:1) mixture of reduced products
11 and 12 (33.9 mg, 0.088 mmol) in THF (5 mL) was added di-tert-butyl dicarbonate
(Boc2O, 42 mg, 0.19 mmol). The reaction mixture was stirred at room temperature until
judged complete by TLC (12 h). After concentration, the two diastereoisomers were
° C; Rf 0.21 (CH2Cl2-EtOAc, 10:1); IR (CCl4) υmax 3430, 2975, 1720, 1695, 1480 cm-1;
MS (FAB) m/z 488 (12, MH+), 388 (16), 332(23), 258 (100); 1H NMR (400 MHz, CDCl3)
δ 1.12 (t, J = 7.0 Hz, 3H), 1.35 (s,3H), 1.41 (s, 9H), 1.46 (s, 9H), 2.17-2.24 (m, 2H), 3.22-
S10
3.37 (m, 4H), 3.90 (bs, 1H), 7.30 (t, J = 7.2 Hz, 2H), 7.44 (t, J = 6.8 Hz, 1H), 7.61 (d, J =
8.0 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 13.6, 18.0, 27.9, 28.5, 30.2, 42.3, 43.5, 54.6,
71.7, 79.3, 81.4, 128.7, 129.1, 138.0, 156.2, 172.9; HRMS (FAB) calcd for C23H38NO580Se:
488.1915, found: 488.1889; Anal. Calcd for C23H37NO5Se: C, 56.78; H, 7.67; N, 2.88.
Found: C, 56.62; H, 7.60; N, 2.89. Minor: light yellow oil; Rf 0.33 (CH2Cl2-EtOAc, 10:1);
IR (CCl4) υmax 3420, 2970, 1720, 1690, 1475 cm-1; MS (FAB) m/z 488 (20, MH+), 388
(38), 332(76), 176 (100); 1H NMR (400 MHz, CDCl3) δ 1.27 (t, J = 7.3 Hz, 3H), 1.37
(s,12H), 1.46 (s, 9H), 1.58-1.63 (m, 2H), 3.46-3.54 (m, 4H), 4.00 (bs, 1H), 7.30 (t, J = 7.2
Hz, 2H), 7.44 (t, J = 6.8 Hz, 1H), 7.61 (d, J = 8.0 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ
13.5, 17.3, 27.7, 28.4, 30.5, 42.0, 43.6, 56.6, 70.2, 79.3 81.2, 128.7, 129.1, 138.1, 156.2,
171.9; HRMS (FAB) calcd for C23H38NO580Se: 488.1915, found: 488.1898; Anal. Calcd for
mL) was added DIBAL (0.56 mL of 1M solution, 0.56 equiv) at –78 °C. The reaction
mixture was stirred 2 h at this temperature, quenched with MeOH (0.5 mL) and NH4Cl (2
mL) and then filtered through celite. The two phases were separated, and the aqueous layer
was extracted with CH2Cl2 (5 x 5 mL). The combined organic layers were washed with
brine (10 mL) and dried with Na2SO4, filtered, and concentrated under reduced pressure to
give 97% (43.2mg) of the diols, which were used for the next step without further
purification. To the CH2Cl2 solution (2 mL) of crude diols (43.2 mg, 0.165 mmol) were
added benzaldehyde dimethyl acetal (28 µL, 0.19 mmol) and a catalytic amount of p-
toluensulfonic acid. The resulting mixture was stirred 3 h at room temperature before being
S11
diluted with CH2Cl2 (20 mL), washed with saturated aq NaHCO3 (5 mL) and brine (5 mL),
and dried with Na2SO4. After filtration and evaporation of the solvent, the residue was
benzylidene acetals 20 and 21. The two diastereoisomers were separated by a second flash
(Hexanes:EtOAc, 4:1); MS (FAB) m/z 350 (18, MH+), 292 (35), 250(59), 188 (71), 57
(100); 1H NMR (400 MHz, CDCl3) δ 0.81 (d, J = 6.7 Hz, 3H), 1.11 (t, J = 7.1 Hz, 3H), 1.47
(s, 9H), 1.67-1.72 (m, 1H), 1.88-1.93 (m, 1H), 2.09-2.15 (m, 1H) 3.26-3.34 (m, 5H), 3.36
(t, J = 11.1 Hz, 1H), 4.12 (dd, J = 11.1 and 4.5 Hz, 1H), 5.18 (s, 1H), 7.37-7.42 (m, 3H),
7.46-7.53 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 12.4, 13.6, 28.5, 31.8, 33.8, 42.3, 43.3,
73.0, 79.0, 81.1, 100.9, 126.0, 128.2, 128.6, 138.6, 155.5; HRMS (FAB) calcd for
C20H32NO4: 350.2331, found: 350.2322; Anal. Calcd for C20H31NO4: C, 68.74; H, 8.94; N,
4.01. Found: C, 68.54; H, 8.90; N, 4.05. Minor compound 21: oil; Rf 0.25
(Hexanes:EtOAc, 4:1); MS (FAB) m/z 350 (17, MH+), 291 (27), 248(11), 188 (90), 57
(100); 1H NMR (400 MHz, CDCl3) δ 1.10 (d, J = 7.0 Hz, 3H), 1.21 (t, J = 7.0 Hz, 3H), 1.46
(s, 9H), 1.57-1.62 (m, 1H), 1.67-1.72 (m, 1H), 1.88-1.93 (m, 1H) 3.26-3.34 (m, 4H), 3.88-
3.93 (m, 1H), 4.03 (dd, J = 11.1 and 1.0 Hz, 1H), 4.10 (dd, J = 11.1 and 2.5 Hz, 1H), 5.49
(s, 1H), 7.37-7.42 (m, 3H), 7.46-7.53 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 11.3, 12.4,
28.5, 32.0, 43.3, 73.8, 79.2, 101.7, 126.0, 128.2, 128.7, 153.9; HRMS (FAB) calcd for
C20H32NO4: 350.2331, found: 350.2326; Anal. Calcd for C20H31NO4: C, 68.74; H, 8.94; N,
S12
S13
S14
S15
S16
S17
S18
S19
S20